{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Mexiletine Hydrochloride is a prescription medication available as oral capsules in 150mg, 200mg, and 250mg strengths, manufactured by Rising Pharma Holdings, Inc. It belongs to the antiarrhythmic class and is used to treat certain irregular heartbeats. This generic drug (ANDA215315) is taken by mouth and should be used under medical supervision. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Mexiletine hydrochloride \u2014 ANDA 202111 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202111", "mediaType": "text/html", "title": "Mexiletine hydrochloride"}], "identifier": "ANDA202111", "issued": "2016-09-16", "keyword": ["public-health", "pharmaceuticals", "medications", "fda", "drug-manufacturers"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Mexiletine hydrochloride"}